Revista: | Brazilian Journal of Pharmaceutical Sciences |
Base de datos: | PERIÓDICA |
Número de sistema: | 000451683 |
ISSN: | 1984-8250 |
Autores: | Dhiman, Priya1 Bhatia, Meenakshi1 |
Instituciones: | 1Guru Jambheshwar University of Science and Technology, Hisar, Haryana. India |
Año: | 2022 |
Volumen: | 58 |
País: | Brasil |
Idioma: | Inglés |
Tipo de documento: | Artículo |
Enfoque: | Analítico, descriptivo |
Resumen en inglés | Within recent past, coronavirus has shaken the whole world. The world faced a new pandemic of novel coronavirus 2019 (SARS-CoV-2/ COVID-19).It has socioeconomically impacted world population a lot in terms of education, economy as well as physical and mental health. This novel coronavirus is notorious enough that put human health at a great risk. Currently, researchers all over the world are trying hard to develop a new drug/vaccine for its treatment. In past decades, the world population has faced various viral infectious illness outbreaks. Influenza A, Ebola, Zika, SARS and MERS viruses had whacked public health and economy. Medical science technology achieved the landmark in developing coronavirus (SARS-CoV-2) vaccines that are approved currently for emergency use. Some of the recently approved vaccines are developed by Pfizer and Moderna, Johnson and Johnson, Gam-COVID-vac (Sputnik V), Bharat Biotech (covaxin) and Oxford-AstraZeneca vaccines (covishield) (Badenet al., 2021). Here, a short review is drafted focusing on infection, immune system, pathogenesis, phylogenesis, mode of transmission and impact of coronavirus on health and economy and recent developments in treating COVID-19 |
Disciplinas: | Medicina |
Palabras clave: | Salud pública, COVID-19, Pandemia, Vacunas, Etnología |
Keyword: | Public health, COVID-19, Pandemia, Vaccines, Ethnology |
Texto completo: | Texto completo (Ver HTML) Texto completo (Ver PDF) |